The partnership will combine Daiichi Sankyo’s clinical trial and preclinical research data with Tempus’ real-world data.

HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation multifunctional biologics across oncology and immune-related diseases, today announced that it ...

Designed to encourage interaction and collaboration, SCOPE X emphasizes detailed case studies, peer-driven discussions, and ...

Moving Beyond Basic AI Adoption, PhaseV Will Demonstrate How Causal AI/ML Achieves Significant Improvements in Trial Design, Execution and Patient Outcomes BOSTON, March 26, 2026 /PRNewswire/ -- ...

Intrinseque Health continues to set the benchmark for excellence by providing strategic and resilient clinical development supply chain solutions. Its unwavering commitment to quality, innovation, and ...

Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced a partnership with ...

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics ...

Q4 2025 Management View CEO Sean McClain reported "a strong fourth quarter," highlighting that ABS-201 is now in the clinic with the first three single ascending dose (SAD) cohorts dosed in the Phase ...

Sujay Jadhav, CEO of Verana Health highlights how real-time real-world data dashboards are transforming the way life sciences ...

In 2021, a global tuberculosis vaccine research and development roadmap proposed a series of actions to accelerate the development of new, effective, and affordable vaccines that are urgently needed ...

Monash University and ClinChoice Inc, a leading global clinical Contract Research Organization (CRO) focused on innovative ...

LTR Pharma recently announced the dosing of the first patients in the Phase II study of SPONTAN ®, which is evaluating the ...